BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21879191)

  • 1. [The role of uric acid in heart failure].
    Alcaíno H; Greig D; Castro P; Verdejo H; Mellado R; García L; Díaz-Araya G; Quiroga C; Chiong M; Lavandero S
    Rev Med Chil; 2011 Apr; 139(4):505-15. PubMed ID: 21879191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradoxical relationship between serum uric acid and cardiovascular disease.
    Lippi G; Montagnana M; Franchini M; Favaloro EJ; Targher G
    Clin Chim Acta; 2008 Jun; 392(1-2):1-7. PubMed ID: 18348869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uric acid as a marker of pathophysiological mechanisms in patients with cardiovascular disease].
    Calberg MJ; Kjøller E
    Ugeskr Laeger; 2005 Oct; 167(40):3771-4. PubMed ID: 16221391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?
    Duan X; Ling F
    Med Hypotheses; 2008; 70(3):578-81. PubMed ID: 17689199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid correlates with extracellular superoxide dismutase activity in patients with chronic heart failure.
    Alcaino H; Greig D; Chiong M; Verdejo H; Miranda R; Concepcion R; Vukasovic JL; Diaz-Araya G; Mellado R; Garcia L; Salas D; Gonzalez L; Godoy I; Castro P; Lavandero S
    Eur J Heart Fail; 2008 Jul; 10(7):646-51. PubMed ID: 18559296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid in CHF: marker or player in a metabolic disease?
    Doehner W; von Haehling S; Anker SD
    Int J Cardiol; 2007 Feb; 115(2):156-8. PubMed ID: 16844250
    [No Abstract]   [Full Text] [Related]  

  • 7. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology.
    Hare JM; Johnson RJ
    Circulation; 2003 Apr; 107(15):1951-3. PubMed ID: 12707249
    [No Abstract]   [Full Text] [Related]  

  • 9. Uric acid, xanthine oxidase and heart failure: unresolved issues.
    Verdejo H; Alcaino H; Greig D; Garcia L; Pizarro M; Chiong M; Castro P; Lavandero S
    Eur J Heart Fail; 2008 Dec; 10(12):1271-2. PubMed ID: 19010082
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical differences between heart failure versus ischemic patients].
    Pinelli M; Bindi M; Moroni F; Rosada J; Castiglioni M
    Recenti Prog Med; 2007; 98(7-8):378-83. PubMed ID: 17685185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure.
    Reyes AJ
    Eur J Heart Fail; 2005 Jun; 7(4):461-7. PubMed ID: 15921780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis.
    Tamariz L; Harzand A; Palacio A; Verma S; Jones J; Hare J
    Congest Heart Fail; 2011; 17(1):25-30. PubMed ID: 21272224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine metabolism in heart failure: oxidant biology and therapeutic indications.
    Bauer JA; Moffatt-Bruce SD; Elton TS; Feldman D
    Congest Heart Fail; 2008; 14(5):283-4. PubMed ID: 18983293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Excretion of uric acid in cardiac decompensation].
    Teodosiev L
    Vutr Boles; 1979; 18(3):218-24. PubMed ID: 475900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in xanthine oxidase activity in patients with circulatory failure].
    Bakhtiiarov ZA
    Ter Arkh; 1989; 61(5):68-9. PubMed ID: 2781495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
    Anker SD; Doehner W; Rauchhaus M; Sharma R; Francis D; Knosalla C; Davos CH; Cicoira M; Shamim W; Kemp M; Segal R; Osterziel KJ; Leyva F; Hetzer R; Ponikowski P; Coats AJ
    Circulation; 2003 Apr; 107(15):1991-7. PubMed ID: 12707250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid and oxidative stress: relative impact on cardiovascular risk?
    Strazzullo P; Puig JG
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid in chronic heart failure: a marker of chronic inflammation.
    Leyva F; Anker SD; Godsland IF; Teixeira M; Hellewell PG; Kox WJ; Poole-Wilson PA; Coats AJ
    Eur Heart J; 1998 Dec; 19(12):1814-22. PubMed ID: 9886724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.